Shoshana Zevin

2.6k total citations · 1 hit paper
45 papers, 1.9k citations indexed

About

Shoshana Zevin is a scholar working on Molecular Biology, Physiology and Epidemiology. According to data from OpenAlex, Shoshana Zevin has authored 45 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 17 papers in Physiology and 11 papers in Epidemiology. Recurrent topics in Shoshana Zevin's work include Nicotinic Acetylcholine Receptors Study (9 papers), Smoking Behavior and Cessation (8 papers) and Lysosomal Storage Disorders Research (7 papers). Shoshana Zevin is often cited by papers focused on Nicotinic Acetylcholine Receptors Study (9 papers), Smoking Behavior and Cessation (8 papers) and Lysosomal Storage Disorders Research (7 papers). Shoshana Zevin collaborates with scholars based in Israel, United States and Netherlands. Shoshana Zevin's co-authors include Neal L. Benowitz, Peyton Jacob, Irith Hadas‐Halpern, Ari Zimran, Ephrat Levy‐Lahad, Peyton Jacob, N L Benowitz, Gideon Nesher, Mihaela Mates and Deborah Elstein and has published in prestigious journals such as The Lancet, Blood and Journal of the American College of Cardiology.

In The Last Decade

Shoshana Zevin

45 papers receiving 1.8k citations

Hit Papers

Drug Interactions with To... 1999 2026 2008 2017 1999 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shoshana Zevin Israel 23 852 594 253 214 171 45 1.9k
N BENOWITZ United States 13 837 1.0× 531 0.9× 68 0.3× 60 0.3× 224 1.3× 15 2.1k
Katarı́na Šebeková Slovakia 34 630 0.7× 568 1.0× 285 1.1× 49 0.2× 226 1.3× 162 3.3k
Flavia Franconi Italy 34 649 0.8× 655 1.1× 362 1.4× 80 0.4× 306 1.8× 113 3.3k
Jane McEneny United Kingdom 35 674 0.8× 601 1.0× 285 1.1× 96 0.4× 669 3.9× 99 3.5k
Mary Walter United States 34 1.3k 1.5× 948 1.6× 322 1.3× 150 0.7× 522 3.1× 103 4.1k
G. Wolfram Germany 32 593 0.7× 458 0.8× 176 0.7× 79 0.4× 192 1.1× 160 3.2k
Raymond Noordam Netherlands 24 565 0.7× 507 0.9× 275 1.1× 48 0.2× 268 1.6× 146 2.4k
Manuela Verri Italy 22 748 0.9× 547 0.9× 170 0.7× 41 0.2× 250 1.5× 63 1.8k
Veli-Pekka Valkonen Finland 19 498 0.6× 447 0.8× 330 1.3× 77 0.4× 508 3.0× 22 2.9k
Hari M. Sharma United States 27 228 0.3× 456 0.8× 134 0.5× 80 0.4× 153 0.9× 95 2.3k

Countries citing papers authored by Shoshana Zevin

Since Specialization
Citations

This map shows the geographic impact of Shoshana Zevin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shoshana Zevin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shoshana Zevin more than expected).

Fields of papers citing papers by Shoshana Zevin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shoshana Zevin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shoshana Zevin. The network helps show where Shoshana Zevin may publish in the future.

Co-authorship network of co-authors of Shoshana Zevin

This figure shows the co-authorship network connecting the top 25 collaborators of Shoshana Zevin. A scholar is included among the top collaborators of Shoshana Zevin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shoshana Zevin. Shoshana Zevin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Assous, Marc V., et al.. (2019). Reducing blood culture contamination using an initial specimen diversion device. American Journal of Infection Control. 47(7). 822–826. 19 indexed citations
3.
Munter, Gabriel, et al.. (2017). Nicotine Addiction and Withdrawal among Orthodox Jews: the Effect of Sabbath Abstinence.. PubMed. 19(1). 25–29. 1 indexed citations
4.
Friedmann, Reuven, et al.. (2016). Operating a Monitoring Unit in the Geriatric Department: Effects on Outcomes. Journal of the American Geriatrics Society. 65(2). 427–432. 1 indexed citations
5.
Hersch, Moshe, et al.. (2015). Prokinetic drugs for gastric emptying in critically ill ventilated patients: Analysis through breath testing. Journal of Critical Care. 30(3). 655.e7–655.e13. 15 indexed citations
6.
Friedmann, Reuven, et al.. (2014). Prosthetic valve endocarditis due to Streptococcus pneumoniae. SpringerPlus. 3(1). 375–375. 2 indexed citations
7.
Segel, Reeval, Yair Anikster, Shoshana Zevin, et al.. (2011). A safety trial of high dose glyceryl triacetate for Canavan disease. Molecular Genetics and Metabolism. 103(3). 203–206. 38 indexed citations
8.
Lachish, Tamar, Bernard Rudensky, Itzchak Slotki, & Shoshana Zevin. (2007). Enoxaparin Dosage Adjustment in Patients with Severe Renal Failure: Antifactor Xa Concentrations and Safety. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 27(10). 1347–1352. 20 indexed citations
9.
Nesher, Gideon, Mihaela Mates, & Shoshana Zevin. (2003). Effect of caffeine consumption on efficacy of methotrexate in rheumatoid arthritis. Arthritis & Rheumatism. 48(2). 571–572. 71 indexed citations
10.
Zevin, Shoshana, et al.. (2001). Cardiovascular effects of carbon monoxide and cigarette smoking. Journal of the American College of Cardiology. 38(6). 1633–1638. 119 indexed citations
11.
Zevin, Shoshana. (2000). Nicotine-mecamylamine interactions. Clinical Pharmacology & Therapeutics. 68(1). 58–66. 20 indexed citations
12.
Zevin, Shoshana. (1998). Clinical pharmacology of nicotine. Clinics in Dermatology. 16(5). 557–564. 74 indexed citations
13.
Zevin, Shoshana, et al.. (1998). Nicotine Transport in a Human Choriocarcinoma Cell Line (JAR). Journal of Pharmaceutical Sciences. 87(6). 702–706. 23 indexed citations
14.
Zevin, Shoshana, Delia Dempsey, & Kent R. Olson. (1997). Amanita phalloidesMushroom Poisoning–Northern California, January 1997. Journal of Toxicology Clinical Toxicology. 35(5). 461–463. 11 indexed citations
15.
Benowitz, Neal L., Shoshana Zevin, & Peyton Jacob. (1997). Sources of variability in nicotine and cotinine levels with use of nicotine nasal spray, transdermal nicotine, and cigarette smoking. British Journal of Clinical Pharmacology. 43(3). 259–267. 113 indexed citations
16.
Benowitz, Neal L., et al.. (1996). Orthostatic Hypertension Due to Vascular Adrenergic Hypersensitivity. Hypertension. 28(1). 42–46. 23 indexed citations
17.
Zimran, Ari, Deborah Elstein, Shoshana Zevin, et al.. (1994). Low-dose enzyme replacement therapy for Gaucher's disease: Effects of age, sex, genotype, and clinical features on response to treatment. The American Journal of Medicine. 97(1). 3–13. 73 indexed citations
18.
Zevin, Shoshana, Aya Abrahamov, Irith Hadas‐Halpern, et al.. (1993). Adult-type Gaucher disease in children: genetics, clinical features and enzyme replacement therapy.. PubMed. 86(9). 565–73. 39 indexed citations
19.
Zimran, Ari, Irith Hadas‐Halpern, Shoshana Zevin, Ephrat Levy‐Lahad, & Aya Abrahamov. (1993). Low‐dose high‐frequency enzyme replacement therapy for very young children with severe Gaucher disease. British Journal of Haematology. 85(4). 783–786. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026